Development of a castrate resistant transplant tumor model of prostate cancer
Abstract
Currently, limited mouse models that mimic the clinical course of castrate resistant prostate development currently exist. Such mouse models are urgently required to conduct pre‐clinical studies to assist in the understanding of disease progression and the development of rational therapeutic strategies to treat castrate resistant prostate cancer.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jul 27, 2011
- Source ID
- 10.1002/pros.21465
Entities
People
- Kristin Lehet
- Leigh Ellis
- Remi Adelaiye
- Roberto Pili
- Swathi Ramakrishnan
Organizations
- National Cancer Institute
- United States Department of Defense